CRONTERA

Welcome to the Brand page for “CRONTERA”, which is offered here for Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases; human pharmaceuticals for use as hemostatic agents;.

Its status is currently believed to be active. Its class is unavailable. “CRONTERA” is believed to be currently owned by “Johnson & Johnson”.